{
    "nctId": "NCT00317148",
    "title": "Phase II-III Placebo-Controlled, Study to Evaluate the Effects of DHEA on Vasomotor Symptoms (Hot Flashes) in Postmenopausal Women",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Healthy postmenopausal women with 50 or more moderate to severe hot flushes"
                    },
                    {
                        "type": "variable",
                        "value": "Women between 40 to 70 years of age"
                    },
                    {
                        "type": "variable",
                        "value": "Must be FEMALE"
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 40 Years"
                    },
                    {
                        "type": "variable",
                        "value": "Must have maximum age of 70 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Body mass index (BMI) of 35 kg/m2 or more"
                            },
                            {
                                "type": "variable",
                                "value": "Significant metabolic and endocrine diseases"
                            },
                            {
                                "type": "variable",
                                "value": "Diagnosis of cancer"
                            },
                            {
                                "type": "variable",
                                "value": "Use of steroids or drugs that interfere with the metabolism of estrogen"
                            },
                            {
                                "type": "variable",
                                "value": "Use of any systemic estrogen, progestin, or DHEA in the eight weeks prior to randomization"
                            },
                            {
                                "type": "variable",
                                "value": "Use of alternative therapies or natural products to treat postmenopausal symptoms in the four weeks prior to randomization"
                            },
                            {
                                "type": "variable",
                                "value": "Palpable fibroids or uterine prolapse: Grade 2 or 3"
                            },
                            {
                                "type": "variable",
                                "value": "Cigarette smoking"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Healthy postmenopausal women with 50 or more moderate to severe hot flushes'), Symbol('Must be FEMALE'), Symbol('Must have maximum age of 70 Years'), Symbol('Must have minimum age of 40 Years'), Symbol('Women between 40 to 70 years of age'), Not(Or(Symbol('Body mass index (BMI) of 35 kg/m2 or more'), Symbol('Cigarette smoking'), Symbol('Diagnosis of cancer'), Symbol('Palpable fibroids or uterine prolapse: Grade 2 or 3'), Symbol('Significant metabolic and endocrine diseases'), Symbol('Use of alternative therapies or natural products to treat postmenopausal symptoms in the four weeks prior to randomization'), Symbol('Use of any systemic estrogen, progestin, or DHEA in the eight weeks prior to randomization'), Symbol('Use of steroids or drugs that interfere with the metabolism of estrogen'))))"
}